Five integrated concepts building Nepal's mountain bio-economy — from extraction science to carbon credits, community livelihoods, and innovation training.
Nepal's medicinal plants are extraordinary. Berberis aristata grown at 2,500m+ contains Berberine concentrations that outperform global averages. Swertia chirayita is WHO-listed and prized in European phytomedicine. Yet Nepal sells them raw. Concept A changes that — with pharmaceutical-grade extraction, HPLC-validated quality, and a zero-waste circular model.
High-purity Berberine alkaloid (≥95% HPLC). Anti-inflammatory, antimicrobial, metabolic health. Global pharma demand: $1.2B market. Target: 500 kg/year by Year 3.
Standardized extract (≥2.5% swertiamarin). WHO-listed. Hepatoprotective, anti-diabetic, skin-active. High value in EU phytomedicine and Ayurvedic markets.
Sustainable nettle fiber (Allo) for luxury textiles and plant protein (Sisno) for nutraceuticals. Low regulatory complexity, direct community income, strong ESG narrative.
Two of Nepal's most underutilized wild plants have quietly extraordinary potential. Allo (Girardinia diversifolia) produces some of the world's finest natural bast fibre — sought by luxury fashion brands in Europe and Japan. Sisno (Urtica dioica) is nutrient-dense and protein-rich — a functional food waiting to be standardized. Together they form a dual-resource circular enterprise anchored in Himalayan communities.
Community decortication → natural fibre extraction → yarn spinning → handloom and semi-mechanized textile production → eco-fashion products for EU and Japanese luxury markets. Natural dye extraction from by-products.
Cleaning → drying → powder production → fortified food products (soups, noodles, protein mixes) → packaging for urban Nepal and international wellness markets. FSSAI/EU food safety compliance pathway.
Nepal's forests generate thousands of tonnes of pine needles annually — currently burned as a fire hazard or left to decay. Michāhā invasive weeds degrade over 30,000 hectares of farmland. HIBH converts both into biochar, biomass pellets, and verified carbon credits — turning ecological problems into economic and climate assets.
Small-scale pyrolysis unit converting Michāhā and pine needle feedstock into biochar. Applied to cultivation plots for soil carbon enhancement. Carbon credits under Verra VM0042 methodology.
Industrial-grade pellets (3,800–4,200 kcal/kg) displacing coal in regional brick kilns and small industry. Carbon avoidance credits under CDM AMS-I.C. methodology. Earliest revenue stream — Year 1.
Estimated 700–2,000 tCO₂e/year by Year 3 across biochar, biomass displacement, and invasive species removal pathways. Revenue: USD $8,000–$35,000/year at voluntary market prices.
The institutional backbone that makes everything else fundable and scalable. HIBH's digital MRV system, blended finance structure, and policy alignment create the governance layer that turns a promising project into a nationally recognized innovation model.
Three-layer monitoring: farm-level mobile data collection, hub-level lab records, satellite-level land cover monitoring via ESA Sentinel-2. Generates simultaneous pharma traceability and carbon credit verification data. QR-based supply chain from farm to buyer.
ADB Technical Assistance Grant ($200–500K) for Phase 1 lab and protocol development. ADB Nature Finance Co-Investment ($2–5M) as first-loss tranche to catalyze private investors. Carbon credit pre-sale forward agreements. Diaspora investment network.
Nepal currently has no field-based biotech training facility in its mountain regions. University graduates in life sciences have theoretical knowledge but no access to hands-on training in molecular extraction, HPLC validation, or digital MRV systems. HIBH's Open Lab changes that.
20+ Nepali university graduates trained annually in HPLC operation, extraction science, GIS mapping, and digital MRV. 3-month structured internship curriculum co-designed with NIC and Tribhuvan University. 60% women trainee target per cohort.
A structured model for Nepali scientists working abroad to return and contribute. Led by Namrata Dhungana — Co-Founder and Biotech Lead returning from Silicon Valley full-time to build and run this programme. HIBH is the proof of concept.